Bonum Therapeutics

Business Services · Washington, United States · 11-50 Employees

View Company Info for Free

Overview

Headquarters

1150 Eastlake Ave E Ste 1100, Seattle, W...

Phone Number

(206) 888-8485

Revenue

$7 Million

Industry

Business Services Manufacturing Pharmaceuticals Research & Development

About Bonum Therapeutics

Bonum Therapeutics is a biotechnology company developing antibody-controlled protein therapeutics that activate only at disease sites. Its dual-binding platform is designed to deliver targeted cytokine medicines for cancer while extending into autoimmune disease, metabolic disorders, and pain management through preclinical pipeline development work.Explore more
Bonum Therapeutics's Social MediaSIC Code 28,283NAICS Code 32,325Show more

Bonum Therapeutics Org Chart

PhoneEmail
Diane Hollenbaugh, Chief Scientific Officer at Bonum Therapeutics
United States flag for contact location.

Chief Scientific Officer

Flame icon indicating likelihood to engage via phone.PhoneFlame icon indicating likelihood to engage via email.Email

PhoneEmail
Get the full picture
Sign in to uncover key details.
NK
United States flag for contact location.

Lab Manager

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Compare Similar Companies to Bonum Therapeutics

Compare insights from companies similar to Bonum Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Bonum Therapeutics

$7M
11-50
Private
$119.9M
2021
Diane Hollenbaugh, Chief Scientific Officer at Bonum Therapeutics
Diane HollenbaughChief Scientific Officer
<$5M
11-50
Private
<$5M
1893
<$5M
11-50
Private
$56M
2019
Melissa Epperly, Chief Financial Officer at Visus Therapeutics
Melissa EpperlyChief Financial Officer
<$5M
11-50
Private
-
-
N/A
<$5M
11-50
Private
$17M
2022
Loong Wang, Co-founder & Chief Technology Officer at Automera
Loong WangCo-founder & Chief Technology Officer
<$5M
11-50
Private
$31M
2021
CW
Carl WalkeyVice President & Head of Business Development
<$5M
1-10
Private
<$5M
2022
Cyriel Notteboom, Co-Founder & Chief Technology Officer at Radical
Cyriel NotteboomCo-Founder & Chief Technology Officer
Illustration of an envelope

Bonum Therapeutics Tech Stack

A closer look at the technologies used by Bonum Therapeutics

Top Business Services Companies

Frequently Asked Questions Regarding Bonum Therapeutics

What is Bonum Therapeutics's official website?
Bonum Therapeutics's official website is www.bonumtx.com
What is Bonum Therapeutics's Revenue?
Bonum Therapeutics's revenue is $7 Million
What is Bonum Therapeutics's SIC code?
Bonum Therapeutics's SIC: 28,283
What is Bonum Therapeutics's NAICS code?
Bonum Therapeutics's NAICS: 32,325
How many employees does Bonum Therapeutics have?
Bonum Therapeutics has 11-50 employees
What industry does Bonum Therapeutics belong to?
Bonum Therapeutics is in the industry of: Business Services, Manufacturing, Pharmaceuticals
What is Bonum Therapeutics competition?
Bonum Therapeutics top competitors include: Monod Bio, Visus Therapeutics, Rubber, JJ Brenner Oyster
What technology does Bonum Therapeutics use?
Some of the popular technologies that Bonum Therapeutics uses are: WordPress.org, PHP, Cloudflare Website Optimization, Cloudflare CDN
How do I contact Bonum Therapeutics?
Bonum Therapeutics contact info: Phone number: (206) 888-8485 Website: www.bonumtx.com
What does Bonum Therapeutics do?

Bonum Therapeutics is a biotechnology company developing antibody-controlled protein therapeutics that activate only at disease sites. Its dual-binding platform is designed to deliver targeted cytokine medicines for cancer while extending into autoimmune disease, metabolic disorders, and pain management through preclinical pipeline development work... .Read More

What are Bonum Therapeutics social media links?
Bonum Therapeutics Linkedin page Bonum Therapeutics Twitter page
Who invested in Bonum Therapeutics?
Bonum Therapeutics has 6 investors including RiverVest Venture Partners, Digitalis Ventures, Codon Capital and Roche Venture Fund.
Is Bonum Therapeutics a public company?
Bonum Therapeutics is private company therefore does not currently have an official ticker symbol
See more information about Bonum Therapeutics

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.